SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-290505
Filing Date
2022-11-22
Accepted
2022-11-22 08:12:05
Documents
15
Period of Report
2022-11-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d313160d8k.htm   iXBRL 8-K 28273
2 EX-99.1 d313160dex991.htm EX-99.1 174913
6 GRAPHIC g313160dsp01.jpg GRAPHIC 9657
7 GRAPHIC g313160g1119062057976.jpg GRAPHIC 3142
  Complete submission text file 0001193125-22-290505.txt   364995

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vivo-20221122.xsd EX-101.SCH 2884
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vivo-20221122_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vivo-20221122_pre.xml EX-101.PRE 10835
9 EXTRACTED XBRL INSTANCE DOCUMENT d313160d8k_htm.xml XML 3266
Mailing Address 3471 RIVER HILLS DRIVE CINCINNATI OH 45244
Business Address 3471 RIVER HILLS DR CINCINNATI OH 45244 5132713700
MERIDIAN BIOSCIENCE INC (Filer) CIK: 0000794172 (see all company filings)

IRS No.: 310888197 | State of Incorp.: OH | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-14902 | Film No.: 221407536
SIC: 2835 In Vitro & In Vivo Diagnostic Substances